Valuation CSPC Pharmaceutical Group Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 12:08:07 30/06/2026 +04			5-day change	1st Jan Change
6.970 ^HKD	-2.52%		+1.90%	-17.32%

06-18	CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA	MT
06-18	CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	79,688	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-17.32%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	68,637	66,352	63,234
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-20.84%	-3.33%	-4.7%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	9.71x	11.3x	10.3x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	1.86x	1.71x	1.55x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.8x	1.09x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.24x	2.27x	2.12x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	1.93x	1.89x	1.68x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	5.23x	6.71x	5.98x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	7.37x	8.63x	7.76x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	8.35x	9.45x	6.6x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	12%	10.6%	15.1%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3591	0.3656	0.3823
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	5.15%	5.25%	5.49%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.7181	0.6159	0.6739
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50%	59.4%	56.7%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,562	35,135	37,621
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,116	9,883	10,578
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,309	7,687	8,151
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,903	6,894	7,534
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,051	-13,336	-16,454
Reference price ²	8.470	8.200	7.260	4.780	8.430	6.970	6.970	6.970
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	9.71x	1.93x	5.23x	5.15%	10.16B
ELI LILLY AND COMPANY	35.06x	12.74x	25.95x	0.57%	1,070B
JOHNSON & JOHNSON	27.14x	6.24x	16.98x	2.1%	611B
ABBVIE INC.	31.04x	7.44x	15.22x	2.75%	445B
ROCHE HOLDING AG	17.73x	4.41x	10.84x	3.01%	329B
ASTRAZENECA PLC	23.3x	4.89x	13.84x	1.78%	290B
NOVARTIS AG	21.86x	5.61x	13.55x	2.82%	287B
NOVO NORDISK A/S	13.89x	5.16x	10.6x	3.6%	213B
AMGEN INC.	23.6x	6.28x	11.05x	2.79%	195B
GILEAD SCIENCES, INC.	-45.11x	5.46x	30.35x	2.57%	157B
Average	15.82x	6.02x	15.36x	2.71%	360.64B
Weighted average by Cap.	24.22x	7.88x	18.19x	2%